An overview of in vitro dissolution testing for film dosage forms

被引:8
|
作者
Zhang, Weifeng [1 ,2 ,3 ]
Xiao, Chaoqiang [2 ,3 ,4 ]
Xiao, Yao [3 ]
Tian, Bing [3 ]
Gao, Di [3 ]
Fan, Weiping [3 ]
Li, Guoxiang [3 ]
He, Shuwang [2 ,3 ]
Zhai, Guangxi [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Key Lab Chem Biol, Minist Educ, Jinan 250012, Peoples R China
[2] Shandong Dyne Marine Biopharmaceut Ltd Corp, Dept Pharmaceut Dev, 18 Fuyuan Nanlu, Rongcheng 264300, Peoples R China
[3] Beijing Dyne High Tech Inst Med Children Ltd Corp, Beijing 100176, Peoples R China
[4] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao 266003, Peoples R China
基金
中国博士后科学基金;
关键词
Film dosage form; Dissolution testing; Dissolution apparatus; Media; Quality control; Biowaiver; HOT-MELT EXTRUSION; ORALLY DISINTEGRATING TABLETS; SIMULATED BIOLOGICAL-FLUIDS; BUCCAL FILMS; THIN-FILMS; QUALITY-CONTROL; PALATABILITY; FORMULATION; FLOW; APPARATUSES;
D O I
10.1016/j.jddst.2022.103297
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Films are a rapidly developing new dosage form, with dozens of products marketed worldwide in the past two decades. Dissolution is a critical quality attribute of film dosage forms. Dissolution tests are used extensively to evaluate film products quality and performance across drug development and manufacturing, including routine quality control for pharmaceutical development and batch release, stability studies, prediction of in vivo per-formance, and biowaiver requests. There are many important factors to consider when developing and imple-menting dissolution tests for film dosage forms, such as apparatus selection, media type and volumes, rotation speed, and sampling times. This review introduces the dissolution apparatuses suitable for film dosage forms, summarizes dissolution methods used for commercial drug products and reported in the literature, discusses the application and significance of dissolution testing in development and evaluation of film drug products, such as commercial films marketed in the US and Japan, and provides a perspective on the future of dissolution testing for films.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] USP Workshop on In Vitro Testing for Meeting Future Challenges for Veterinary Dosage Forms
    Marques, Margareth R. C.
    DISSOLUTION TECHNOLOGIES, 2017, 24 (01): : 44 - 54
  • [32] Biorelevant In Vitro Performance Testing of Orally Administered Dosage Forms—Workshop Report
    Christos Reppas
    Horst-Dieter Friedel
    Amy R. Barker
    Lucinda F. Buhse
    Todd L. Cecil
    Susanne Keitel
    Johannes Kraemer
    J. Michael Morris
    Vinod P. Shah
    Mary P. Stickelmeyer
    Chikako Yomota
    Cynthia K. Brown
    Pharmaceutical Research, 2014, 31 : 1867 - 1876
  • [33] CHARACTERIZATION OF THE IN-VITRO DISSOLUTION OF SOME COMMERCIAL SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORMS
    VEIGA, F
    SIMOES, S
    MOREIRA, JN
    SOUSA, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (08) : 1471 - 1483
  • [34] SIMULATION OF THE IN VIVO EXPOSURE TO IBUPROFEN BASED ON IN VITRO DISSOLUTION PROFILES FROM SOLID DOSAGE FORMS
    Popa, Daniela Elena
    Lupuliasa, Dumitru
    Stanescu, Ana-Andreea
    Barca, Maria
    Dragomiroiu, George Traian Alexandru Burcea
    Miron, Dalia Simona
    Radulescu, Flavian Stefan
    FARMACIA, 2014, 62 (03) : 475 - 485
  • [35] QUANTITATIVE CORRELATION OF ABSORPTION AND IN-VITRO DISSOLUTION KINETICS OF ASPIRIN FROM SEVERAL DOSAGE FORMS
    GIBALDI, M
    WEINTRAUB, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (05) : 725 - +
  • [36] Differences between the branded and generic solid dosage form medicines: in vitro dissolution testing
    Al Ameri, M. N.
    Nayuni, N.
    Kumar, A.
    Perrett, D.
    Tucker, A.
    Johnston, A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 984 - 984
  • [37] CONVENTIONAL VERSUS NOVEL CONDITIONS FOR THE IN-VITRO DISSOLUTION TESTING OF PARENTERAL SLOW-RELEASE FORMULATIONS - APPLICATION TO DOXEPIN PARENTERAL DOSAGE FORMS
    GIDO, C
    LANGGUTH, P
    KREUTER, J
    WINTER, G
    WOOG, H
    MUTSCHLER, E
    PHARMAZIE, 1993, 48 (10): : 764 - 769
  • [38] TESTING STABILITY OF ERGOMETRINE DOSAGE FORMS
    ELMASRY, S
    MANUFACTURING CHEMIST AND AEROSOL NEWS, 1978, 49 (09) : 53 - 53
  • [39] MICROBIAL TESTING OF ORAL DOSAGE FORMS
    SCHNELLER, GH
    DRUG & COSMETIC INDUSTRY, 1978, 122 (02): : 48 - &
  • [40] Excipients for Novel Inhaled Dosage Forms: An Overview
    Carol Yousry
    Mimansa Goyal
    Vivek Gupta
    AAPS PharmSciTech, 25